S139: INTERIM ANALYSIS OF A REGISTRATION ENABLING STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) A CD123-TARGETING ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)

Detalles Bibliográficos
Autores principales: Pemmaraju, Naveen, Martinelli, Giovanni, Montesinos, Pau, Mazzarella, Luca, Deangelo, Daniel J., Erba, Harry, Sweet, Kendra, Walter, Roland, Deconinck, Eric, Legrand, Ollivier, Wang, Eunice, Aribi, Ahmed, Ulrickson, Matthew, Marconi, Giovanni, Lane, Andrew, Kantarjian, Hagop, Sloss, Callum, Malcolm, Kara, Zweidler-Mckay, Patrick, Daver, Naval
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428302/
http://dx.doi.org/10.1097/01.HS9.0000967468.85099.f4
Descripción
Sumario:

Ejemplares similares